ReCor Medical Expands Its Medical Advisory Board

Published: Sep 28, 2012

MENLO PARK, Calif.--(BUSINESS WIRE)--Click here for video interviews

ReCor Medical announced today that it has expanded its medical advisory board in anticipation of conducting post-market clinical studies of its next-generation PARADISEĀ® System for treatment of resistant hypertension via renal denervationā€”the only system for renal denervation that is based on ultrasound, not radiofrequency, energy. The new medical advisors are: Peter J. Fitzgerald, M.D., Ph.D., Stanford University School of Medicine, Stanford, Calif.; Thomas Mabin, M.D., Vergelegen Medi-Clinic, South Africa; Krishna J. Rocha-Singh, M.D., Praririe Cardiovascular, Springfield, Ill; and Karl-Heinz Kuck, M.D., Ph.D., Asklepios Klinik, Hamburg, Germany.

Back to news